Site Members can sign up for company wide alerts
Investigation Overview
Sept. 3, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Medicis Pharmaceutical Corp (NYSE:MRX) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Medicis Pharmaceutical Corp for $44.00 per NYSE:MRX share and the takeover process are unfair to investors in Medicis Pharmaceutical shares. The investigation ...
You must register (for free) or login to view the entire investigation.